Lazard Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,567
| Closed | -$84K | – | 2657 |
|
|
2022
Q1 | $84K | Buy |
20,567
+3,831
| +23% | +$15.6K | ﹤0.01% | 1483 |
|
|
2021
Q4 | $59K | Buy |
16,736
+9,580
| +134% | +$33.8K | ﹤0.01% | 1666 |
|
|
2021
Q3 | $26K | Buy |
+7,156
| New | +$26K | ﹤0.01% | 1959 |
|
|
2021
Q2 | – | Sell |
-15,178
| Closed | -$62K | – | 2139 |
|
|
2021
Q1 | $62K | Buy |
15,178
+1,265
| +9% | +$5.17K | ﹤0.01% | 1357 |
|
|
2020
Q4 | $55K | Sell |
13,913
-6,649
| -32% | -$26.3K | ﹤0.01% | 1357 |
|
|
2020
Q3 | $55K | Sell |
20,562
-1,397
| -6% | -$3.74K | ﹤0.01% | 1162 |
|
|
2020
Q2 | $60K | Buy |
21,959
+4,213
| +24% | +$11.5K | ﹤0.01% | 1182 |
|
|
2020
Q1 | $41K | Buy |
17,746
+8,235
| +87% | +$19K | ﹤0.01% | 1264 |
|
|
2019
Q4 | $44K | Buy |
9,511
+5,337
| +128% | +$24.7K | ﹤0.01% | 1088 |
|
|
2019
Q3 | $13K | Buy |
+4,174
| New | +$13K | ﹤0.01% | 1244 |
|